Holen Sie sich die Stockscreener-App
0.7206
3.55%
0.0247
Handel nachbörslich:
.74
0.0194
+2.69%
Schlusskurs vom Vortag:
$0.6959
Offen:
$0.69
24-Stunden-Volumen:
121.79K
Relative Volume:
0.11
Marktkapitalisierung:
$54.43M
Einnahmen:
$11.03M
Nettoeinkommen (Verlust:
$-44.24M
KGV:
-1.1623
EPS:
-0.62
Netto-Cashflow:
$-42.61M
1W Leistung:
+3.05%
1M Leistung:
-12.12%
6M Leistung:
-27.21%
1J Leistung:
-15.22%
1-Tages-Spanne:
$0.69
$0.737
1-Wochen-Bereich:
$0.6686
$0.737
52-Wochen-Spanne:
$0.5837
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
Firmenname
Hyperfine Inc
Sektor
Branche
Telefon
866-796-6767
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Vergleichen Sie HYPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.7206 | 54.43M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2022-04-14 | Eingeleitet | Wells Fargo | Overweight |
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com
Hyperfine enrolls initial patients in NEURO PMR study - TipRanks
Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan
HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView
HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com
Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN
Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia
Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com
Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener
Hyperfine initiated with a Buy at Lake Street - TipRanks
What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St
Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks
B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey
Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks
Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq
Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News
Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer
Hyperfine Inc (HYPR) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
NVIDIA partners with Hyperfine on Swoop MRI AI system - MSN
Earnings call transcript: Hyperfine Q4 2024 reports mixed results By Investing.com - Investing.com Australia
Hyperfine, Inc. Reports 2024 Financial Results and Strategic Expansion - TipRanks
Earnings call transcript: Hyperfine Q4 2024 reports mixed results - Investing.com India
Hyperfine earnings matched, revenue fell short of estimates - Investing.com
Hyperfine Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Hyperfine shares tumble as Q4 revenue misses estimates By Investing.com - Investing.com South Africa
Hyperfine shares tumble as Q4 revenue misses estimates - Investing.com
HYPERFINE Earnings Results: $HYPR Reports Quarterly Earnings - Nasdaq
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Hyperfine reports Q4 EPS (14c), consensus (14c) - TipRanks
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - Nasdaq
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable - Benzinga
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation - 01net
Hyperfine, NVIDIA Partner to Transform Neuroimaging with AI - Medical Product Outsourcing
Hyperfine Collaborating With Nvidia to Improve Portable MRI Technology; Shares Jump - Marketscreener.com
Hyperfine partners with NVIDIA to enhance portable MRI tech - Investing.com India
Hyperfine partners with NVIDIA to enhance portable MRI tech By Investing.com - Investing.com Australia
Earnings Scheduled For March 17, 2025 - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
HYPERFINE Earnings Preview: Recent $HYPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Hyperfine (HYPR) Projected to Post Earnings on Monday - Defense World
When Will Portable MRI Pioneer Hyperfine Reveal Its 2024 Performance? - StockTitan
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire
Insider Selling: TEISSEYRE THOMAS, Hyperfine Inc [HYPR] Chief Operating Officer divested 3,237 shares - Knox Daily
Hyperfine COO Thomas Teisseyre sells $3,884 in stock By Investing.com - Investing.com Australia
Hyperfine COO Thomas Teisseyre sells $3,884 in stock - Investing.com India
Hyperfine reports growing evidence supporting use of Swoop system images in stroke diagnosis - NeuroNews International
Finanzdaten der Hyperfine Inc-Aktie (HYPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):